dr. gingrey, the next step focus primary on promoting antibiotics to be used in limited populations. is there anything that you believe we should keep in mind as we trapped this legislation? >> i feel that a strong signal from congress to the health care community about stewardship would be extremely important. fda frequently approves drugs for limited population, but usually there isn't that sort of an orphan population. there isn't that sort of temptation they will use a broadly in a much broader population. so one of the main things is a signal from congress that it's fine to do limited population out of their broader disease with a very small development program, but then it should be that stewardship by the health care community to not use it more broadly. >> i know if you do with any infectious disease specialties they talk about that, and can we statutorily, because i know in medical practice a doctor make a decision on their own and that may be part of the problem. but you can't limit it to just, for example, people who deal with infectious diseases. >> we feel there shouldn'

dr. gingrey from georgia. mr. gingrey: i thank the gentleman for yielding. i did want to speak about the young people. and i -- and i'm talking about those who have their 27th birthday, they're age 27 so they're not eligible any longer to be on their parents' health insurance plan. i have concerns over the effects of this law on these young people and i have warned for some time an even introduced legislation to insulate the young from rate hikes which are the direct result of these age ban provisions in the affordable care act. health insurance companies know, their actuarians know, they've studied they've gone to college, gotten masters, figuring egrees, in out what the premiums need to be at different age bands and the federal government has come along in this law and said, well, it doesn't matter, you can't charge any more than three times the premium for, let's say, a 62-year-old versus a 28-year-old. and what that is doing, of course, is making the insurance companies just simply raise the premium for everybody. so they can possibly make a profit. and

dr. gingrey, a member of the health subcommittee. the speaker pro tempore: the gentleman from georgia is recognized for unwp -- for one minute. mr. gingrey: mr. speaker, the gentleman from new york just said it. universal health care. single-payer system. government takeover of 1/6 of our economy. that's what they wanted from the very beginning. i rise today in support of h.r. 3350, the keep your health plan act now. the obama administration's health exchange enrollment announcement on wednesday is one of the myriad reasons we must pass this bill. frankly, these long-awaited numbers did not come as a surprise to us. a mere 100,000 registered for health care on the new marketplace when they anticipated 500,000. according to health and human services' report, the number does not distinguish even between those who have actually paid a premium and those who just select the plan by kicking a button on the website. mr. speaker, the number of americans who have had their health plans canceled is in the millions, exponentially higher than th

dr. gingrey. >> mr. chairman, thank you very much for yielding, and i, too, am pleased to see the doctors here again today. the bill looked to address the crisis of antibiotic resistance with title viii, the gain act, which i wrote with my colleagues, mr. green, mr. shimkus, ms. degette, mr. whitfield and ms. eshoo. by focusing on incentives to bring new drugs to market, we have seen renewed focus on development of cutting edge drugs, antibiotics. however, even with the early success of this program, i do believe that we need to do more. and so, mr. chairman, cdc had a september report, cdc and my great capital city of atlanta, georgia, on antimicrobial resistance highlights 18 known resistance threats. it's estimated across the country more than two million people are sickened every year with infections resulting in at least 23,000 deaths. 23,000 deaths. i look forward to continuing to work with the fda to create innovative pathways and processes. we must make sure that the agency and drug developers ha

dr. gingrey, a member of the health subcommittee. the speaker pro tempore: the gentleman from georgia is recognized for unwp -- for one minute. mr. gingrey: mr. speaker, the gentleman from new york just said it. universal health care. single-payer system. government takeover of 1/6 of our economy. that's what they wanted from the very beginning. i rise today in support of h.r. 3350, the keep your health plan act now. the obama administration's health exchange enrollment announcement on wednesday is one of the myriad reasons we must pass this bill. frankly, these long-awaited numbers did not come as a surprise to us. a mere 100,000 registered for health care on the new marketplace when they anticipated 500,000. according to health and human services' report, the number does not distinguish even between those who have actually paid a premium and those who just select the plan by kicking a button on the website. mr. speaker, the number of americans who have had their health plans canceled is in the millions, exponentially higher than th